Business
This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana...
As using psychedelics as medicines for mental health conditions has become more popular, it has been an open question of...
In today’s episode, I talk with Matt Stang, CEO of Delic Corp. Delic (OTCMKTS: DELCF) is a psychedelic medicines company...
Scientists Create A New DMT: Can it Treat Depression? | Psychedelic Therapy When it comes to treating mental health conditions...
This week in psychedelic business news: Wesana Health files a new patent, Silo Pharma is granted a patent, and 2...
Further in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically targeting alcohol consumption....
What are the benefits of Microdosing psilocybin? | Interview with a Microdosing Expert In today’s episode, we sit down with...
This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a Cybin study for Covid-19 distress;...
During our time in Wonderland Miami, we had the pleasure to meet and interview Dr. Matthew Johnson of Johns Hopkins...
Chief Medical Officer Dr. Guy Goodwin clarifies "COMP360 psilocybin therapy was generally well-tolerated" by patients with treatment-resistant depression, despite some...